Transcription factors as targets for cancer therapy
暂无分享,去创建一个
[1] David Baltimore,et al. Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism , 1986, Cell.
[2] D. Baltimore,et al. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. , 1986, Cell.
[3] H. Varmus. Oncogenes and transcriptional control. , 1987, Science.
[4] R. Doolittle,et al. Homology between the DNA-binding domain of the GCN4 regulatory protein of yeast and the carboxyl-terminal region of a protein coded for by the oncogene jun. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[5] J. Sklar,et al. TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms , 1991, Cell.
[6] P. Vogt,et al. A rearranged junD transforms chicken embryo fibroblasts. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[7] M. Karin,et al. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain , 1994, Cell.
[8] T. Maniatis,et al. Virus induction of human IFNβ gene expression requires the assembly of an enhanceosome , 1995, Cell.
[9] R. Jove,et al. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. , 1995, Science.
[10] Dwight C. Look,et al. Stat1 Depends on Transcriptional Synergy with Sp1 (*) , 1995, The Journal of Biological Chemistry.
[11] Christel Brou,et al. Signalling downstream of activated mammalian Notch , 1995, Nature.
[12] P. Shaw,et al. Activation of ternary complex factor Elk-1 by stress-activated protein kinases , 1995, Current Biology.
[13] D. Denhardt. Oncogene-initiated aberrant signaling engenders the metastatic phenotype: synergistic transcription factor interactions are targets for cancer therapy. , 1996, Critical reviews in oncogenesis.
[14] D. Goeddel,et al. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[15] M. Castellazzi,et al. Stepwise transformation of rat embryo fibroblasts: c-Jun, JunB, or JunD can cooperate with Ras for focus formation, but a c-Jun-containing heterodimer is required for immortalization , 1996, Molecular and cellular biology.
[16] J. Darnell. STATs and gene regulation. , 1997, Science.
[17] S. Artavanis-Tsakonas,et al. Neoplastic transformation by truncated alleles of human NOTCH1/TAN1 and NOTCH2 , 1997, Molecular and cellular biology.
[18] R Berger,et al. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. , 1997, Science.
[19] Alain Israë. Signal transduction: IκB kinase all zipped up , 1997, Nature.
[20] M. Scott,et al. Altered neural cell fates and medulloblastoma in mouse patched mutants. , 1997, Science.
[21] D. Gallahan,et al. The mouse mammary tumor associated gene INT3 is a unique member of the NOTCH gene family (NOTCH4) , 1997, Oncogene.
[22] Hans Clevers,et al. Armadillo Coactivates Transcription Driven by the Product of the Drosophila Segment Polarity Gene dTCF , 1997, Cell.
[23] D. Goldfarb,et al. Evolutionary specialization of the nuclear targeting apparatus. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[24] G. Stark,et al. How cells respond to interferons. , 1998, Annual review of biochemistry.
[25] P. Ingham,et al. Transducing Hedgehog: the story so far , 1998, The EMBO journal.
[26] M. Wolter,et al. Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. , 1998, Cancer research.
[27] L. Wojnowski,et al. Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome , 1998, Nature Medicine.
[28] P. Barnes,et al. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. , 1998, Clinical science.
[29] S. Artavanis-Tsakonas,et al. Notch signaling: cell fate control and signal integration in development. , 1999, Science.
[30] B. Rayet,et al. Aberrant rel/nfkb genes and activity in human cancer , 1999, Oncogene.
[31] J. Darnell,et al. Interacting Regions in Stat3 and c-Jun That Participate in Cooperative Transcriptional Activation , 1999, Molecular and Cellular Biology.
[32] Andrius Kazlauskas,et al. Diverse Signaling Pathways Activated by Growth Factor Receptors Induce Broadly Overlapping, Rather Than Independent, Sets of Genes , 1999, Cell.
[33] E. Prochownik,et al. MYC oncogenes and human neoplastic disease , 1999, Oncogene.
[34] P. S. Kim,et al. Inhibiting HIV-1 Entry Discovery of D-Peptide Inhibitors that Target the gp41 Coiled-Coil Pocket , 1999, Cell.
[35] S. Akira,et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. , 1999, Immunity.
[36] A. Ruiz i Altaba,et al. Gli proteins and Hedgehog signaling: development and cancer. , 1999, Trends in genetics : TIG.
[37] A. R. I. Altaba. Gli proteins and Hedgehog signaling: development and cancer. , 1999 .
[38] A. Shaywitz,et al. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. , 1999, Annual review of biochemistry.
[39] J. Turkson,et al. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. , 1999, Immunity.
[40] J. Darnell,et al. Stat3 as an Oncogene , 1999, Cell.
[41] J E Darnell,et al. A nuclear protein tyrosine phosphatase is required for the inactivation of Stat1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[42] D. Hilton,et al. Negative regulation of the JAK/STAT pathway , 1999, BioEssays : news and reviews in molecular, cellular and developmental biology.
[43] J. Grandis,et al. STAT signaling in head and neck cancer , 2000, Oncogene.
[44] R. Berger,et al. Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells. , 2000, Blood.
[45] J. Russo,et al. Activation of NF-kappaB/Rel occurs early during neoplastic transformation of mammary cells. , 2000, Carcinogenesis.
[46] K. Shuai,et al. Modulation of STAT signaling by STAT-interacting proteins , 2000, Oncogene.
[47] Y. Liaw,et al. Constitutive activation of nuclear factor κB in hepatocellular carcinoma , 2000 .
[48] R. Roeder,et al. Transcriptional regulation through Mediator-like coactivators in yeast and metazoan cells. , 2000, Trends in biochemical sciences.
[49] Philip A Beachy,et al. Hedgehog-Regulated Processing of Gli3 Produces an Anterior/Posterior Repressor Gradient in the Developing Vertebrate Limb , 2000, Cell.
[50] B. Groner,et al. Regulation of the trans-activation potential of STAT5 through its DNA-binding activity and interactions with heterologous transcription factors. , 2000, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[51] G. Weinmaster. Notch signal transduction: a real rip and more. , 2000, Current opinion in genetics & development.
[52] P. Leder,et al. Ras pathway signals are required for notch-mediated oncogenesis , 2000, Oncogene.
[53] N. Perkins. The Rel/NF-κB family: friend and foe , 2000 .
[54] J. Silvio Gutkind,et al. Signaling Networks and Cell Cycle Control , 2000 .
[55] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[56] J. Gibbs. Mechanism-based target identification and drug discovery in cancer research. , 2000, Science.
[57] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[58] L. Miele,et al. Notch signaling as a target in multimodality cancer therapy. , 2000, Current opinion in molecular therapeutics.
[59] Roy Garcia,et al. STATs in oncogenesis , 2000, Oncogene.
[60] R. Eisenman,et al. The Myc/Max/Mad network and the transcriptional control of cell behavior. , 2000, Annual review of cell and developmental biology.
[61] Y. Liaw,et al. Constitutive activation of nuclear factor kappaB in hepatocellular carcinoma. , 2000, Cancer.
[62] P. Polakis. Wnt signaling and cancer. , 2000, Genes & development.
[63] E. Fearon,et al. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin. , 2000, Genes & development.
[64] D. Kalderon. Transducing the Hedgehog Signal , 2000, Cell.
[65] H Clevers,et al. Catenins, Wnt signaling and cancer. , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.
[66] A. Hamilton,et al. Peptide and protein recognition by designed molecules. , 2000, Chemical reviews.
[67] Kathleen R. Cho,et al. γ-Catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of β-catenin , 2000, Genes & Development.
[68] B. Groner,et al. Cooperation Among Stat1, Glucocorticoid Receptor, and PU.1 in Transcriptional Activation of the High-Affinity Fcγ Receptor I in Monocytes1 , 2000, The Journal of Immunology.
[69] A G Cochran,et al. Antagonists of protein-protein interactions. , 2000, Chemistry & biology.
[70] J. Darnell,et al. Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[71] F. McCormick,et al. Replication-selective viruses for cancer therapy , 2002, Journal of Molecular Medicine.
[72] T. Hunter,et al. Oncogenic kinase signalling , 2001, Nature.
[73] J. Taipale,et al. The Hedgehog and Wnt signalling pathways in cancer , 2001, Nature.
[74] Karine Hovanes,et al. β-catenin–sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer , 2001, Nature Genetics.
[75] J. Nevins,et al. The E2F1–3 transcription factors are essential for cellular proliferation , 2001, Nature.
[76] D. Gilliland. The diverse role of the ETS family of transcription factors in cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[77] W. Tam,et al. Cell-Specific Association and Shuttling of IκBα Provides a Mechanism for Nuclear NF-κB in B Lymphocytes , 2001, Molecular and Cellular Biology.
[78] F. McCormick,et al. Cancer gene therapy: fringe or cutting edge? , 2001, Nature Reviews Cancer.
[79] Hormones and cancer: new insights, new challenges , 2001, Trends in Endocrinology & Metabolism.
[80] E. Birney,et al. Cancer and genomics , 2001, Nature.
[81] S. Alkan,et al. Characterization of NF-κB Expression in Hodgkin’s Disease: Inhibition of Constitutively Expressed NF-κB Results in Spontaneous Caspase-Independent Apoptosis in Hodgkin and Reed-Sternberg Cells , 2001, Modern Pathology.
[82] F. Oswald,et al. p300 Acts as a Transcriptional Coactivator for Mammalian Notch-1 , 2001, Molecular and Cellular Biology.
[83] J. Nesland,et al. Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[84] E. Brambilla,et al. Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinoma , 2001, Oncogene.
[85] S. Fan,et al. β‐catenin mutation and overexpression in hepatocellular carcinoma , 2001 .
[86] Robert L Davis,et al. Vertebrate hairy and Enhancer of split related proteins: transcriptional repressors regulating cellular differentiation and embryonic patterning , 2001, Oncogene.
[87] R. Eisenman,et al. Deconstructing myc. , 2001, Genes & development.
[88] J. Herman,et al. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity , 2001, Nature Genetics.
[89] S. Fan,et al. beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance. , 2001, Cancer.
[90] J. Darnell,et al. Constitutively activated Stat 3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat 1 , 2001 .
[91] S. Alkan,et al. Analysis of expression of nuclear factor κB (NF‐κB) in multiple myeloma: downregulation of NF‐κB induces apoptosis , 2001 .
[92] Hans van Dam,et al. Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis , 2001, Oncogene.
[93] P. Vogt,et al. Jun, the oncoprotein , 2001, Oncogene.
[94] D. Kalderon,et al. Proteolysis of the Hedgehog Signaling Effector Cubitus interruptus Requires Phosphorylation by Glycogen Synthase Kinase 3 and Casein Kinase 1 , 2002, Cell.
[95] J. Darnell,et al. Signalling: STATs: transcriptional control and biological impact , 2002, Nature Reviews Molecular Cell Biology.
[96] D. Green,et al. A Matter of Life and Death , 2008, Science.
[97] S. Sebti,et al. Inhibitors of protein farnesyltransferase as novel anticancer agents. , 2002, Current Topics in Medicinal Chemistry.
[98] J. Bishop,et al. Suppressor of Fused represses Gli-mediated transcription by recruiting the SAP18-mSin3 corepressor complex , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[99] L. Staudt,et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. , 2002, The New England journal of medicine.
[100] David S. Parker,et al. Pygopus, a nuclear PHD-finger protein required for Wingless signaling in Drosophila. , 2002, Development.
[101] A. Hamilton,et al. Modulation of protein–protein interactions by synthetic receptors: Design of molecules that disrupt serine protease–proteinaceous inhibitor interaction , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[102] A. Brivanlou,et al. Signal Transduction and the Control of Gene Expression , 2002, Science.
[103] D. Botstein,et al. Gene expression patterns in human liver cancers. , 2002, Molecular biology of the cell.
[104] Alison Abbott,et al. Cancer research: On the offensive , 2002, Nature.
[105] L. Staudt,et al. Molecular diagnosis of lymphoid malignancies by gene expression profiling. , 2002, Current opinion in hematology.
[106] D. Boger,et al. Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[107] Sandipan Chatterjee,et al. Wnt/wingless Signaling Requires Bcl9/legless-mediated Recruitment of Pygopus to the Nuclear Beta-catenin-tcf Complex , 2022 .
[108] A nuclear protein tyrosine phosphatase TC-PTP is a potential negative regulator of the PRL-mediated signaling pathway: dephosphorylation and deactivation of signal transducer and activator of transcription 5a and 5b by TC-PTP in nucleus. , 2002, Molecular endocrinology.
[109] Qian Zhang,et al. Multilevel Dysregulation of STAT3 Activation in Anaplastic Lymphoma Kinase-Positive T/Null-Cell Lymphoma1 , 2002, The Journal of Immunology.
[110] Kevin M. McBride,et al. Regulated nuclear import of the STAT1 transcription factor by direct binding of importin‐α , 2002, The EMBO journal.
[111] Mariann Bienz,et al. A new nuclear component of the Wnt signalling pathway , 2002, Nature Cell Biology.